US Patent 7488477 Neutralizing monoclonal antibodies to respiratory syncytial virus
Patent 7488477 was granted and assigned to Intracel Resources, LLC on February, 2009 by the United States Patent and Trademark Office.
All edits
The present invention relates to the identification and cloning of a novel neutralizing human monoclonal antibody to the Respiratory Syncytial Virus. The invention provides such antibodies, fragments of such antibodies retaining RSV-binding ability, chimeric antibodies retaining RSV-binding ability, and pharmaceutical compositions including such antibodies. The invention further provides for isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith. Finally, the invention provides for diagnostic and therapeutic methods employing the antibodies and nucleic acids of the invention.
US Patent 07488477 Neutralizing monoclonal antibodies to respiratory syncytial virus US Patent 7488477 Neutralizing monoclonal antibodies to respiratory syncytial virus
US Patent 07488477 Neutralizing monoclonal antibodies to respiratory syncytial virus
Find more entities like US Patent 7488477 Neutralizing monoclonal antibodies to respiratory syncytial virus
